Arcutis Biotherapeutics Inc ARQT
$25.61 $0.59 (2.25%) 1D
Last Updated: Aug 17, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
ARQT Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Arcutis Biotherapeutics Inc is classified as halal.
HALAL
Report Source: undefined Quarter Report
Arcutis Biotherapeutics Inc. Stock Analysis ARQT
United States Health Care Mid Cap Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. The company is headquartered in Westlake Village, California and currently employs 354 full-time employees. The company went IPO on 2020-01-31. The firm is focused on developing and commercializing treatments for dermatological diseases with high-unmet medical needs. Its portfolio is comprised of topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. Its lead product, ZORYVE, is for the treatment of plaque psoriasis, including psoriasis in the intertriginous areas, in individuals 12 years of age or older. The ZORYVE is also indicated for topical treatment of mild to moderate atopic dermatitis. ZORYVE cream is a once-daily topical formulation of roflumilast, a potent and selective phosphodiesterase-4 (PDE4) inhibitor. The Company’s pipeline includes ARQ-255, ARQ-252, and ARQ-234. Its ARQ-255 is being developed for the treatment of alopecia areata. ARQ-252 is an alternative topical cream formulation of ivarmacitinib that the Company is developing for chronic hand eczema and vitiligo.
Arcutis Biotherapeutics Inc (ARQT) Chart
Financial Metrics & Statements of Arcutis Biotherapeutics Inc (ARQT)
FAQ's for Arcutis Biotherapeutics Inc (ARQT)
- As of August 2026, Arcutis Biotherapeutics Inc ARQT is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Arcutis Biotherapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Arcutis Biotherapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Arcutis Biotherapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Arcutis Biotherapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Arcutis Biotherapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Arcutis Biotherapeutics Inc (ARQT)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
